Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up Women only

Mindfulness-based sleep program for pregnant women to prevent depression

Official title: Sleep to Reduce Incident Depression Effectively in Peripartum

Run by Henry Ford Health System · NCT06430333 · Data updated 2026-11-12

This study is testing a mindfulness-based sleep program to see if it can help pregnant women with insomnia reduce their risk of depression.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment500 (estimated)
SponsorHenry Ford Health System
Academic / other
Locations1 site (Novi, Michigan)
StatusRecruiting
StartedDecember 10, 2024
Main results expectedFebruary 29, 2028
Study endsFebruary 29, 2028
Registry record updatedApril 17, 2026
Trial IDNCT06430333 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women between 14 to 31 weeks of gestation who have been diagnosed with insomnia disorder.

Probably not a fit

Patients with high-risk pregnancies or those currently experiencing major depression may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of a mindfulness-based sleep program called Perinatal Understanding of Mindful Awareness for Sleep (PUMAS) in reducing the risk of perinatal depression (PND) among pregnant women experiencing insomnia. The study will involve 500 women who are between 14 to 31 weeks of gestation and have been diagnosed with insomnia disorder. Participants will receive either the PUMAS intervention or treatment-as-usual (TAU) while their sleep quality, cognitive arousal, and depressive symptoms are monitored. The trial seeks to address the high prevalence of insomnia and its link to PND, particularly in the context of the COVID-19 pandemic.

Why it matters

Potential benefit: If successful, this program could significantly reduce the incidence of perinatal depression in pregnant women by improving their sleep quality.

How similar studies have gone: Previous studies have shown promising results with mindfulness-based interventions for insomnia and depression, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Singleton pregnancy, gestational week 14-31 at screening.
2. DSM-5 Insomnia Disorder (≥1 month duration).
3. Insomnia Severity Index (ISI) score ≥ 11.
4. Edinburgh Postnatal Depression Scale score\<13 at screening.
5. No current DSM-5 Major Depression.
6. Reliable internet access for treatment and assessments.
7. Not currently engaged in therapy for major depression or insomnia disorder.
8. Age 18 years or older.

Exclusion Criteria:

1. High risk pregnancy (pre-eclampsia, placenta previa w/ hemorrhage, other conditions deemed serious risk to mother or fetus; hypertension and diabetes are allowed).
2. Active suicidal intent.
3. Night or rotating shift work, anticipated travel across time 3 or more time zones in the 2 months after baseline screening.
4. Untreated RLS (treated RLS is OK).
5. Excessive daytime sleepiness; Epworth Sleepiness Scale\>15.
6. Uncontrolled sleep or mental disorder inappropriate or unsafe for sleep restriction (narcolepsy, bipolar, epilepsy, etc.).

Where it's running

  • Henry Ford Medical Center
    Novi, Michigan, United States
    Recruiting

Study contacts

  • Principal investigator: David A Kalmbach, PhD — Henry Ford Health
  • Study coordinator: David A Kalmbach, PhD
  • Email: dkalmba1@hfhs.org
  • Phone: 248-325-3938

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.